Published: June 2024 · Last updated: August 2026
Healthcare margins are thinner than they’ve been in years, and Group Purchasing Organizations (GPOs) alone can no longer close the gap. This piece breaks down what GPOs do well, where non-clinical spend hides untapped savings, and how healthcare organizations can build a more complete cost-reduction strategy.
Why Are Healthcare Costs Still Rising Despite GPOs?
Healthcare costs keep climbing because of inflation, tariffs, and the impact of the One Big Beautiful Bill Act. Margin pressure now demands savings from non-clinical categories — IT, facilities, logistics — that GPOs were never built to negotiate, leaving most non-clinical spend unmanaged.
Labor costs remain elevated, supply expenses haven’t settled back to pre-pandemic norms, and reimbursement pressure shows no sign of easing. For most health systems, the default response is to lean harder on GPOs.
That instinct isn’t wrong — GPOs remain one of the most reliable tools for controlling clinical spend. But the organizations making real progress are looking past that single lever and asking where else money is leaking out, unnoticed and unmanaged.
What is a Group Purchasing Organization: Benefits and Limitations
A Group Purchasing Organization pools the buying power of many healthcare providers to negotiate better pricing on goods and services than any single organization could get alone. For clinical products — pharmaceuticals, medical devices, surgical supplies — this model works well. Manufacturers compete for large-volume contracts, and hospitals benefit from standardized pricing across a broad catalog of items they buy constantly and predictably.
Advantages of Group Purchasing Organizations
Among the advantages of employing GPOs for clinical spend are:
- Lower prices through collective bargaining
- Reduced administrative burden from having contracts already negotiated
- Access to a vetted supplier network.
Limitations of Group Purchasing Organizations
But GPOs were built for clinical spend, not for the complex, more fragmented world of non-clinical procurement.
- Categories like corporate services, distribution and logistics, facilities management, furniture and fixed assets, information technology, and marketing don’t fit neatly into a national contract.
- Needs vary too much by region, by facility, and by vendor relationship.
- GPOs typically address only somewhere between 12% and 25% of an organization’s non-clinical expenditures.
- GPO spend commitments create healthcare supply chain challenges, such as limiting supplier choice and shifting procurement risk onto health systems.
That gap matters more than it might seem because of how much of the budget it represents.
What Is Non-Clinical Spend in Healthcare?
Non-clinical spend covers indirect purchases — IT, facilities, logistics, marketing, and corporate services — that never touch patient care directly but can consume up to 20% of a health system’s net patient revenue.
Unlike pharmaceuticals or implants, these categories rarely have a single owner. Purchasing decisions get made department by department, often by staff whose primary job has nothing to do with procurement.
Because no GPO is managing this spend, it rarely gets benchmarked against what other industries — retail, manufacturing, logistics — pay for comparable services. That combination of fragmentation and inattention makes non-clinical spend a significant, overlooked source of healthcare inefficiencies.
Where Do Healthcare Organizations Lose Money on Non-Clinical Spend?
Savings typically leak through five recurring gaps: limited spend visibility, fragmented supplier contracts, inconsistent rates across facilities, weak cross-industry benchmarking, and contracts that go years without renegotiation.
- Limited visibility: many systems lack a consolidated view of non-clinical spend, so opportunities stay hidden.
- Fragmented suppliers: departments or facilities contract separately for similar services, losing volume leverage.
- Inconsistent rates: multi-site systems often pay different prices for the same service across locations.
- Weak benchmarking: non-clinical rates get compared only to other healthcare organizations, missing cheaper peer-industry pricing.
- Stale contracts: agreements sit unchanged for years while market pricing shifts underneath them.
4 Ways to Reduce Operational Costs in Healthcare Beyond GPOs
Four practices close the non-clinical savings gap: benchmarking against non-healthcare industries, bringing in category-specific experts, building real-time spend visibility, and staying continuously engaged with supplier markets year-round.
1. Benchmark outside healthcare.
Non-clinical categories like logistics, facilities, and IT aren’t unique to hospitals — comparing rates against retail and manufacturing often reveals savings healthcare-only benchmarks miss.
2. Bring in category expertise.
Few internal procurement teams have deep knowledge across every non-clinical category; specialized advisors bring market insight and negotiating leverage.
3. Build real visibility.
Centralized, ongoing spend data — not scattered department records — makes it possible to see trends and act on them as they happen.
4. Stay engaged with the market.
Rates shift constantly; continuous engagement keeps pricing competitive instead of relying on a once-a-year contract review.
What Does a Stronger Healthcare Procurement Operating Model Look Like?
A stronger model combines continuous sourcing, local vendor relationships where relevant, near-real-time market intelligence, and contracts tailored to each organization — rather than annual rebids built around a fixed vendor list.
- Continuous sourcing, rather than an annual or biannual rebid cycle, leaves pricing outdated for months at a time.
- Local sourcing, where it makes sense, since many non-clinical categories are genuinely regional and benefit from vendors who understand local market conditions.
- Near-real-time market intelligence, so decisions reflect current pricing rather than terms negotiated a year or more ago.
- Contracts tailored to the organization’s actual circumstances, instead of a one-size-fits-all agreement built around a predetermined list of vendors.
None of this replaces the value a GPO provides on clinical spend. It fills in the space GPOs were never designed to cover.
How Healthcare Providers Can Start Reducing Inefficiencies
Start small: audit one or two non-clinical categories, such as IT or facilities, and check when rates were last benchmarked. That single step usually surfaces the first wave of savings opportunity.
For most organizations, that exercise alone is enough to reveal real opportunity and build the case for a more disciplined, ongoing approach to non-clinical spend management.
If you’re curious what that kind of audit might reveal for your organization, we’re happy to walk through what we typically see in a first review.
About the Author
Mark Van Sumeren
Board Observer and Chair, Healthcare and Life Sciences
Mark Van Sumeren is the strategic advisor of the healthcare practice at LogicSource. He is a supply chain expert with 35 years of experience in business strategy and healthcare consulting. Mark has spent his career supporting health systems across the industry, including large, academic medical centers, integrated delivery networks, and for-profit health companies.
